This summer, Technavio released a report titled "CBD Oil Market by Product and Geography - Forecast and Analysis" highlighting the CBD market's growth which is accelerating at a CAGR of 26.43% and is expected to witness an incremental growth of USD 3.97 billion between 2021 and 2026. Judging by recent news in the industry, this growth forecast looks almost conservative.
The deal space is starting to heat up in CBD, recently High Tide Inc. (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused CBD company with bricks-and-mortar as well as global e-commerce assets, announced into an agreement with Echelon Wealth Partners Inc. who have agreed to purchase 4,310,400 units from HITI, at a price of C$2.32 per Unit for total gross proceeds of approximately C$10,000,000. This news came on the heels of HITI’s Blessed CBD subsidiary, launching sales of its CBD products on Amazon (NASDAQ:AMZN) in the UK. In order to sell on Amazon UK, retailers are required to have received Novel Foods Authorization from the Food Standards Agency. Investors have benefited.
Real Brands, Inc. (OTCMKTS: RLBD) could be on the precipice of similar announcements. RLBD CEO Thom Kidrin announced earlier this year that “once the company uplisted” he would have 5 major deals to announce. Well, RLBD has uplisted and announced what seems to be the first big domino.
Real Brands has entered into an LOI to acquire Boulder Botanicals and its full portfolio of popular CBD products with over 150 proprietary formulations, 27,000 sq. foot R&D and production facility, and most importantly, its distribution channels. Boulder is in CVS, Sam’s Club, Target, Whole Foods, Safeway, Costco, 7-Eleven, and Circle K and more. This could be the first of many catalyst producing announcements. RLBD is backed by some big names, Turning Points Brands, Inc. (NYSE: TPB) is a 23% owner, the company is also connected to large private hedge fund Standard General who owns around 20% of TPB and has nearly $1 Billion in AUM. David Glazek is chairman of TPB and founded SG; both companies have a representative on RLBD’s board! This could get interesting. Leveraging investors of this scale increases the potential size of these forthcoming deals.
Turning Point produces, markets, and distributes HUGE brands Zig Zag, Stokers and Beechnut. TPB started to enter the alternative smoking space with products such as a nicotine vapor line and a CBD line, Nu-X. Although, RLBD may be TPB’s best entry into the space.
RLBD has a full suite of products ranging from Seltzer, to tinctures, and almost everything in between.
The OTC market has favored companies like RLBD recently. MariMed, Inc. (CSE: MRMD) (OTCMKTS: MRMD), for instance, has been on quite a bull run, and recently announced its listing on the Canadian Securities Exchange.
“We are excited to announce this significant milestone of our dual listing on the CSE,” said Robert Fireman, Chief Executive Officer of MariMed. “We believe listing on the CSE will increase liquidity for our shareholders and provide access to a significant pool of prospective retail and institutional investors, as well as potential additional Wall Street analyst coverage.”
MariMed's shares will continue to trade on the OTCQX under the ticker symbol MRMD.
MariMed Inc., a multi-state CBD operator, with top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. Represents a business trajectory RLBD seems to be on.
Other CBD companies in the news include The Valens Company Inc. (NASDAQ:VLNS) and OrganiGram Holdings Inc. (NASDAQ:OGI) who both announced impressive revenue increases in their Q2 financials.
Start your research on RLBD here:https://capitalgainsreport.com/rlbd-best-way-to-invest-in-6-trillion-dollar-market/
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport ‘CGR’ is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR is compensated ten thousand dollars monthly via wire transfer by Washington Capital to produce and syndicate content related to RLBD. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.